Cassava Sciences | PTIE - Capital Ordinaire





Capital Ordinaire Changement Date
Abbott USD 1.74B 2.94M 2026-03
Amgen USD 541M 0 2026-09
Biogen USD 146.7M 200K 2025-09
Cara Therapeutics USD 9.38M 2.01K 2026-03
Cassava Sciences USD 48.31M 0 2026-06
Eisai JPY 282.46M 345K 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Geron USD 640.9M 2.54M 2026-03
J&J USD 2.41B 1.64M 2026-06
Merck USD 2.47B 1.05M 2026-06
Novartis USD 1.89B 12.09M 2026-09
Novavax USD 162.58M 106K 2025-12
Pfizer USD 5.7B 0 2026-06
Roche Holding CHF 796.77M 1.15M 2026-06